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RNA interference (RNAi) is the process of mRNA degradation induced by double-stranded RNA in a sequence-speciﬁc manner.




lys promoters. Compared to the vectors with tRNA
lys or U6 promoter, the vector with a CMV enhancer-tRNA
lys promoter
silenced pokemon more eﬃciently on both the mRNA and the protein levels. Meanwhile, the silencing of pokemon inhibited the
proliferation of MCF7 cells, but the induction of apoptosis of MCF7 cells was not observed. We conclude that the CMV enhancer-
tRNA
lys promoter may be a powerful tool in driving intracellular expression of shRNA which can eﬃciently silence targeted
gene.
Copyright © 2009 Ma Weiwei et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
RNAi was ﬁrst discovered in the nematode Caenorhabditis
elegant [1], after which the power and utility of RNAi for
speciﬁcally gene silencing has driven its incredibly rapid
adoption as a tool for reverse genetics at the organismal level.
In mammalian cultured cells, RNAi is typically induced by
siRNAintroduceddirectlyorexpressedasahairpinstructure
from a DNA construct, such as a plasmid, a viral vector, or a
PCR product. It is known that the choice of promoters has
been shown to be very important for eﬃcient RNAi [2–4]
a n dt h u sr e c e i v e dm o r ea n dm o r ec o n c e r ni nv e c t o r - b a s e d
expression systems after the introduction of vectors[4]. The
promoters U6 and H1 [5–15], which belong to Pol III, are
widely used for inducible knock-down of gene expression in
v i t r oo ri nv i v o[ 16] .T y p eI IP o lI I Ip r o m o t e r ss u c ha st R N A
lead to longer primary dsRNAs than U6 or H1, which might
induce interferon response that could be avoided by a careful
design of vector system [6, 17, 18]. It has been reported
t h a tt R N Ap r o m o t e r sa r em o r ee ﬀective in target gene knock
down [6, 17]. Recently, a polymerase I promoter with high
species speciﬁc has also been reported, which provides an
interesting potential regarding the biosafety of experiments
[19].
The CMV enhancer has been used in many vectors
since it could increase the downstream DNA element’s
transcription level [20–22]. Recent studies have compared
the inhibition of exogenous SOD1G93AGFP expression by
CMV enhancer with U6 promoter and U6 promoter alone,
and the results have shown a more eﬃcient inhibition by the
use of CMV enhancer [5]. However, silencing by enhancer-
promoter constructs has not been compared with promoters
alone for endogenous genes.
PokemonisaPOKproteinfamilymember,aspeciﬁcARF
suppressor, whose expression level is a critical determinant
of cellular response to oncogenic transformation, Pokemon
acts as a genuine proto-oncogene when overexpressed [23].
It is thought that downregulated Pokemon could upregulate
ARF, thus blocking MDM2, followed by the increase in p53
expression, and p53’s activation may lead to apoptosis [24].
In this study, we constructed two kinds of shRNA
expression vectors controlled, respectively, by tRNAlys and2 Journal of Biomedicine and Biotechnology
Table 1: Sequences of oilgonucleotides used in the research.
shRNA Sequences of oilgonucleotides
Target site on pokemon mRNA
(GenBank accession number
NM 015898)
1F 1 : 5  -ccgtgtacgagatcgacttcttcaagagagaagtcgatctcgtacacgtttttt-3  383–401nt
R1: 3 -ccggggcacatgctctagctgaagaagttctctcttcagctagagcatgtgcaaaaaatcga-5 
2F 2 : 5  -ccggcttagacttctatgggttcaagagacccatagaagtctaagccgtttttt-3  809–827nt
R2: 3 -ccggggccgaatctgaagatacccaagttctctgggtatcttcagattcggcaaaaaatcga-5 
3F 3 : 5  -cgggcgtcatggactactacttcaagagagtagtagtccatgacgccctttttt-3  1202–1200nt
R3: 3 -ccgggcccgcagtacctgatgatgaagttctctcatcatcaggtactgcgggaaaaaatcga-5 
shRNA encoding cassettes 1–3 were formed by annealing two corresponding oligonucleotides, respectively. F stands for forward and R for reverse.
CMV enhancer-tRNAlys, in order to examine their eﬃciency.
We then use the best shRNA to knock-down Pokemon
expression and to observe the subsequent eﬀect.
2.MaterialsandMethods
2.1. Plasmid Construction. The human tRNAlys promoter
was PCR-ampliﬁed from genomic DNA isolated from HeLa
cells. Primers used for the generation of tRNAlys were
P(Lys1): 5 -GAT GAT ATC TGG CCA CTA GGG ACT GGG-
3 , and P(Lys2): 5 -GTC GGA TCC AAG CTT GAA TTC
GGG CCC AGT CTG ATG CTC TAC CGA CTG-3. The
PCR product was digested with BamHI and EcoRV and then
named tRNAlys promoter.
The plasmid backbone with CMV enhancer was PCR-
ampliﬁed from plasmid pCMV5. Primers used were
P(MRV1): 5 -GTG GAT ATC GGG GCG GGG TTA TTA
CGAC-3 ,andP(MRV2):5 -CGACTCTAGAGGATCCCG
GGT G-3 . The PCR product was digested with BamHI and
EcoRV and then named pCBE. Through ligation of tRNAlys
promoter and pCBE, a novel vector was created and thus
designated as pExsiler, which derived from pCMV5 through
replacing CMV minimal promoter with tRNAlys promoter.
In order to obtain the plasmid containing one tRNAlys
promoter without CMV enhancer, the pCMV5 plasmid was
ﬁrst digested with BamHI, EcoRI, followed by HindII to
completely remove the CMV enhancer sequence and CMV
minimal promoter. The processed plasmid fragment was
named pBE. Through ligation of tRNAlys promoter and pBE,
a new vector was created and thus designated as pSiler, which
derived from pCMV5 through replacing CMV promoter
(CMV enhancer and CMV minimal promoter) with tRNAlys
promoter.
The fragment of human Pokemon cDNA was PCR-
ampliﬁed from cDNA isolated from MCF7 cells. Primers
usedinthisPCRwereP(POK1):5 -CTTAAGCTTGCCACC-
ATGGCCGGCGGCGTGG-3 , and P(POK2): 5 -CATGAT-
ATCGGCGAGTCCGGCTGTGAAGTTAC-3 . The PCR
product was digested with HindIII and EcoRV and then
cloned into the HindIII/SmaI sites of pEGFP(N2). The
recombinant plasmid was named pEGFP(N2)-Pokemon.
SiRNA target sequences of human Pokemon gene were
designed using the Takara siRNA Design Support System
(http://www.takara.com.cn/enter.htm). Among the 10 tar-
get sequences identiﬁed by this free online software,three
target sequences were selected as follows: (1) CGTGTA-
CGAGATCGACTTC; (2) CGGCTTAGACTTCTATGGG;
(3) GGGCGTCATGGACTACTAC. According to these
three target sequences, the sense strands and antisense
strands of duplex shRNA oligonucleotides were synthesized
as shown in Table 1.
These single strand oligonucleotides were phosphory-
lated,andthenF1andR1,F2andR2,andF3andR3oligonu-
cleotides were annealed to generate the duplex oligonu-
cleotides named as FR1, FR2, and FR3. FR1, FR2, and FR3
duplex oligonucleotides were cloned into the ApaI/HIndIII
sites of pExsiler and pSiler, and the resulting plasmids were
named EP1, EP2, EP3, SP1, SP2, and SP3, respectively.
FR3 double-stranded oligonucleotides were cloned into the
ApaI/HIndIII sites of pBS/U6(kindly provided by Yang Shi of
Harvard University) to createthe plasmid designated as UP3.
In order to obtain a control plasmid with only TTTTTT
sequence at the shRNA site, a PCR was preformed, using
P(WW1): 5 -GTC GAT ATC AGA TCT TGA CAT TGA TTA
TTG ACT AGT TAT TAA TAG 3 , and P(WW2): 5 -GTC
GGA TCC AAA AA AGG GCC CAG TCT GAT GCT CTA
CCG ACT G-3  as primers and pExsiler as the template. The
PCR product was digested with BamHI and EcoRV and then
cloned into pBE. The resulting plasmid was named ET as a
control plasmid.
2.2. Cell Culture and Transfection of Cells. Human galac-
tophore cancer cell line MCF-7 was cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Invitrogen) supple-
mented with 10% fetal bovine serum (FBS) (Hyclone),
2mM glutamine (Invitrogen), 100U/mL penicillin, and
100mg/mL streptomycin at 37
◦C in a humidiﬁed 5%CO2
incubator.
For western blot and the detection of apoptosis, twenty-
four hours before transfection, 5 × 105 MCF-7 cells were
trypsinized and transferred to 6-well plates and cultured
in DMEM supplemented with 10%FBS without antibiotics.
They were grown to a conﬂuency of 90%–95% and then
transfected with a total of 4μg of each of the hairpin
vectors using lipofectamine 2000 (Invitrogen) according to


















































Figure 1: Map of construscts used in this work. SP1, SP2 and SP3 plasmids derived from the pSiler plasmid can express shRNA1, shRNA2,
and shRNA3, respectively. EP1, EP2 and EP3 plasmids derived from the pExsiler plasmid can express shRNA1, shRNA2, and shRNA3,
respectively. UP3 plasmid derived from pBS/U6 plasmid can express shRNA3. As control, ET plasmid derived from the pExsiler plasmid can
express no shRNA. pEGFP(N2)-Pokemon derived from pEGFP-N2 vector can express Pokemon-GFP fusion protein.
volume was reduced to 1.5mL in order to obtain higher
transfection eﬃciency. For the screening of the RNAi
plasmids, separate pEGFP(N2)-Pokemon plasmid encoding
Pokemon-GFP fusion protein and the RNAi plasmids were
generally used at a ratio of 1:1 [16]. Exogeneous GFP-
Pokemon protein expression levels of EGFP were assessed by
green ﬂuorescent signals expression under a microscope. For
the detection of cell proliferation, 1 × 104 MCF-7 cells were
trypsinized and transferred to 96 well plates, and cultured
in DMEM supplemented with 10% FBS without antibiotics.
They were immediately transfected with 0.2μgo fe a c ho f
the hairpin vectors using lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol.
2.3. Real Time RT-PCR. 36 hours after transfection, MCF-
7 cells were collected and washed three times with cold
phosphate buﬀered saline (PBS). Total cellular RNA was
prepared using Trizol reagent (Invitrogen). 1μgo ft o t a lR N A
was reverse transcribed (RT) using Superscript II (Invitro-
gen) and random hexamers according to the manufacturer’s
protocol. 1μL cDNA was added to 19μLR e a l M a s t e r m i x
(SYBRGreen)(TIANGEN)containing1xRealMasterMix,1x
SYBR Green (TIANGEN), 200nM of sense primer FW (5 -
GAA GCC CTA CGA GTG CAA CAT C-3 ), and 200nM of
antisense primer ReV (5 -GTG GTT CTT CAG GTC GTA
GTT GTG -3 )[ 23]. Real time PCR was carried out in an
ABI Appied Biosystem 7500 (Applied Biosystems) using the
followingthermalcyclingproﬁle:94





◦C 40 seconds). For RNA normalization, a GAPDH PCR
was performed with the same PCR reagents except that the
primers were G1 (5 - GGT GGT CTC CTC TGA CTT CAA
CA -3 )a n dG 2 (5  -GTT GCT GTA GCC AAA TTC GTT




Figure 2: Expression of Pokemon-GFP in MCF7 cells cotransfected with the pEGFP(N2)-Pokemon and diﬀerent shRNA expression
plasmids. (a) MCF7 cells cotransfected with the pEGFP(N2)-Pokemon and SP1, (b) with the pEGFP(N2)-Pokemon and SP2, (c) with
the pEGFP(N2)-Pokemon and SP3, (d) with the pEGFP(N2)-Pokemon and EP1, (e) with the pEGFP(N2)-Pokemon and EP2, (f) with the
pEGFP(N2)-Pokemon and EP3, and with the (g) pEGFP(N2)-Pokemon and ET.
2.4. Western Blot. MCF-7 cells were collected 48 hours after
transfection. Cells were washed with cold PBS three times
and collected in 500μL PBS using a cell scraper and trans-
ferred into an Eppendorf tube. Following centrifugation,
cells were resuspended in PBS. Cells were lysed in TNE
lysis buﬀer (10mM Tris, pH 7.8, 150mM NaCl, 1mM
EDTA, 0.5% NP-40) containing protease inhibitor PMSF.
After 30-minutes incubation on ice, the lysates were spun at
12000g for 15 minutes to remove insoluble material. Pro-
tein concentrations were determined through the Bradford
procedure. 20μg of total protein lysates were resolved on
a 12% SDS-PAGE gel and transferred to a Nitrocellulose
membrane(Lifesciences).Membraneswereblockedwith5%
nonfat dried milk powder in TBS/T (0.05% Tween-20) for
2 hours at room temperature. Membranes were sequentially
incubated with LRF (E-15) (Santa Cruz sc-34510) and
donkey antigoat IgG-HRP (Santa Cruz sc-2020) according
to the manufacture’s protocol. The protein bands were
visualized using SuperSignal West Pico Chemiluminescent
Substrate(PIERCE)accordingtothemanufacture’sprotocol.
For sequential probing, membranes were stripped in
Erasure buﬀer (2% SDS, 62.5mM Tris-HCl PH 6.8, 100mM
beta-mercaptoethanol) at 70
◦C for 40 minutes and then
incubated in TS buﬀer (10mM Tris-HCl PH 7.4, 150mM
NaCl). Actin bands were then detected using polyclone anti-
body rabbit anti β-actin PR-0255 (ZHONGSHAN GOLD-
BRIDGE, Beijing, China) and HRP labeled antibody goat











EP3 SP3 UP3 ET Normal
Relative pokemon/GAPDH mRNA level
Figure 3: Eﬃciency of diﬀerent shRNA constructs in the inducing
of silencing on Pokemon/GAPDH mRNA level as quantiﬁed by
real-time RT-PCR. Total RNA was extracted from MCF-7 cells
36 hours after transfection with the indicated constructs. Normal
MCF-7 cells were used as a negative control. An external standard
curve was created to make sure that Pokemon and GAPDH
were ampliﬁed at similar eﬃciency. Data shown represents, three
replicated experiments with error bar indicated.
EP3 SP3 UP3 ET Normal
Pokemon
β-actin
Figure 4: Eﬃciency of diﬀerent shRNA constructs in the inducing
of silencing of endogenous gene expression. The western blot shows
the Pokemon bands and the β-actin bands which serve as an
endogenous control.
2.5. Detection of Cell Proliferation. The proliferation rate of
cell line MCF-7 was measured with a Cell proliferation Kit
II (Roche Ltd, Switzerland) according to the manufacturer’s
protocol.
2.6. Flow Cytometric Determination of Apoptosis. 60 hours
after transfection, MCF-7 cells were trypsinized and resus-
pended in PBS. Cells from 2 wells of a 6-well plate were
collected and centrifuged, and the pellets were used for the
ﬂowcytometricdeterminationofapoptosisusingANNEXIN
V-FIFC APOPTOSIS DETECTION KIT I (BD biosciences)
according to the manufacture’s protocol. Cells treated with
10μg/mL cisplatin served as a positive control.
3. Results
3.1. Construction of Plasmids. To compare the eﬃciencies of
CMV enhancer-tRNAlys promoter and tRNAlys promoter, we
constructed two kinds of expression vectors (pExsiler and
pSiler )and attached dsRNA to the 3  end of each promoter.
All plasmids (pExsiler, pSiler, pEGFP(N2)-Pokemon, EP1,
EP2, EP3, SP1, SP2, SP3, UP3, and ET) were sequenced






































Figure 5: Eﬀe c to fp r o l i f e r a t i o no fc e l l st r a n s f e c t e dw i t hd i ﬀerent
shRNA constructs. Rates of proliferation were determined as
described in the text. Data are mean values from three replicates
with error bar indicated. MCF-7 cells transfected with EP3 prolifer-
ateare signiﬁcantly more slowly than cells transfected with control
p l a s m i dE T .T h ew i l dt y p eM C F - 7c e l l sw e r en o ts h o w n .
sequencesoftheallaforementionedplasmidswereconsistent
with what we had designed (Figure 1).
3.2. Eﬃciency of RNAi between Diﬀerent shRNA Expression
Plasmids. For selection of most eﬃcient shRNA from the
three shRNA sequences of human Pokemon gene, the EP1,
EP2, EP3, SP1, SP2, SP3, and ET plasmids were respectively,
cotransfected together with the pEGFP(N2)-Pokemon into
MCF7cells.Pokemon-GFPexpressionwithinthetransfected
cells was assayed by green ﬂuorescent signals (Figure 2).
Whereas EP2 and SP2 had less eﬀect on Pokemon-GFP
expression, EP3 and SP3 greatly diminished its expres-
sion. Therefore, the shRNA derived from target sequences
(GGGCGTCATGGACTACTAC) has most eﬃciency in
knockdown of Pokemon expression.
3.3. Eﬃciency of RNAi between Diﬀerent Expression Plasmids.
To examine the eﬃciency of RNAi in MCF-7 cells, we intro-
duced expression plasmids EP3/SP3/UP3/ET into MCF-7
cellswhichexpressPokemon.WeexaminedPokemonmRNA
levels through real time RT-PCR. As shown in Figure 3,
there is no obvious decrease of Pokemon/GAPDH mRNA
level in cells transfected with ET. However, cells transfected
with EP3, SP3, and UP3 show decreased relative Poke-
mon/GAPDH mRNA levels to 1.2%±0.2%, 12.3%±2.2%,
and 11.1%±1.3%, respectively, compared to normal MCF-7
cells.
Western blot was used to examine the Pokemon expres-
sion level. Figure 4 shows that the Pokemon expression level
in MCF7 cells transfected with EP3 was signiﬁcantly lower
than those with SP3, UP3 and ET, whereas the β-actin
expression levels remained unchanged. These results suggest
that the enhancer-promoter construct can speciﬁcally and
eﬃcientlysilencePokemononbothmRNAandproteinlevels
in MCF-7 cells.
3.4. Eﬀects of Pokemon Inhibition. To examine the phenotype

























































































Figure 6: Flow cytometric determination of apoptosis. (a) Unstained normal MCF-7 cells (b) EP3-transfected cells stained with both PI
and Annexin V-FITC (c) ET-transfected cells stained with both PI and Annexin V-FITC (d) Cisplatin-treated cells stained with both PI
and Annexin V-FITC. Note that some cells transfected with PT were dead as a result of high cell density. Results are representative of two
replicates.
the proliferation rates of MCF-7 were analyzed. As shown
in Figure 5, MCF-7 cells transfected with EP3, in which
Pokemon levels were reduced signiﬁcantly both on mRNA
and protein scale, proliferated much more slowly than cells
transfected with ET, which was served as a negative control.
The reduction of proliferation rate is believed to be at least
partially due to the decrease of Pokemon protein level in
MCF-7 cells.
Recent research has suggested that the inhibition of
Pokemon might result in the apoptosis or the cell cycle arrest
[23]. However, in the present study, no typical apoptosis
was observed by Flow Cytometry in MCF-7 cells transfected
by EP3 and ET, while cells treated with cisplatin did show
apoptosis (Figure 6).
4. Discussions
In the present study, we found that CMV enhancer, one
of the widely used enhancers, could increase the eﬃciency
of tRNAlys promoter. It has been reported that the com-
munication between the enhancer and the promoter could
induce gene activation [26], while the disruption of the
communication leads to the inhibition of gene expression
[27]. Therefore, enhancers may activate the transcription
of downstream shRNA, resulting in the increase of RNAi
eﬃciency.
Pokemon, also known as LRF, OCZF, and FBI-1, is a
POK protein family member, a speciﬁc ARF suppressor,
whose expression level is a critical determinant of cellular
response to oncogenic transformation. So Pokemon acts as
a genuine proto-oncogene when over-expressed [23]. It is
thought that downregulated Pokemon results in an increase
in p53 expression, and p53’s activation may lead to apoptosis
[24]. In our study, no apoptosis but the slower proliferation
rate is observed in the inhibition of Pokemon in MCF-
7 cells induced by shRNA controlled by CMV enhancer
with tRNAlys promoter. However, as the ARF/p53 pathway
is frequently abrogated in human cancers, if MCF-7 cells do
lose this path, this apparent discrepancy could be solved.
What is more, current evidences show that Pokemon nullJournal of Biomedicine and Biotechnology 7
mouse resultedin embryonic lethal dueto severeanemia and
profoundly impaired diﬀerential cellular in multiple tissues
[23]. But MCF-7 cells are already diﬀerentiated cells; thereby
they may avoid apoptosis for that reason. However, more
investigation should be made to conﬁrm our ﬁndings.
In conclusion, the shRNA expression vector controled by
CMV enhancer-tRNAlys promoter is powerful in silencing
Pokemon and may be a useful tool for scientiﬁc research and
therapy use with RNAi.
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